Ipratropium Adultes Eg (Ipratropium Bromide)

Ipratropium Adultes Eg is an anticholinergic bronchodilator used to treat airway obstruction in chronic respiratory diseases.

• Chronic obstructive pulmonary disease (COPD): improves airflow and reduces exacerbations.
• Asthma: provides bronchodilation to relieve bronchospasm.
• Bronchospasm associated with COPD or asthma: offers rapid relief of airway narrowing.

• Ipratropium bromide acts as a competitive antagonist at muscarinic (M3) acetylcholine receptors on airway smooth muscle. By blocking acetylcholine‑mediated bronchoconstriction, it prevents calcium influx and promotes relaxation of the bronchial smooth muscle, resulting in bronchodilation and improved airflow. The drug is delivered via inhalation, allowing direct action on the respiratory tract with minimal systemic absorption.

Ipratropium Adultes Eg may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects

• Dry mouth: sensation of reduced salivation.
• Cough: irritation of the airway.
• Throat irritation: discomfort in the throat.
• Headache: mild to moderate pain.
• Dizziness: transient light‑headedness.
• Nausea: mild gastrointestinal upset.

Serious or Rare Side Effects

• Paradoxical bronchospasm: worsening airway narrowing.
• Angioedema: swelling of face, lips or tongue.
• Severe allergic reaction: rash, hives, anaphylaxis.
• Tachycardia: rapid heart rate.
• Urinary retention: difficulty emptying bladder.
• Increased intraocular pressure: risk of glaucoma exacerbation.

When prescribing Ipratropium Adultes Eg, clinicians should consider several safety measures.

• Assess respiratory status: evaluate baseline lung function before initiation.
• Monitor for paradoxical bronchospasm: discontinue if worsening symptoms occur.
• Use with caution in narrow‑angle glaucoma: anticholinergic effect may raise intraocular pressure.
• Use with caution in patients with urinary retention: may exacerbate symptoms.
• Avoid in known hypersensitivity: discontinue if allergic reaction develops.
• Store at room temperature: keep in original packaging, protect from moisture and light.

Ipratropium Adultes Eg can interact with other medications, requiring attention to potential additive effects.

Major Interactions (Avoid)

• Concurrent use with other inhaled anticholinergics (e.g., tiotropium): may increase anticholinergic burden.
• Combination with beta‑2 agonists at high doses: may elevate risk of cardiovascular side effects.

Moderate Interactions (Monitor Closely)

• Use with antihistamines: may enhance dry‑mouth sensation.
• Use with diuretics: monitor electrolyte balance.
• Use with drugs that cause urinary retention (e.g., antihistamines, tricyclic antidepressants): observe for worsening retention.